Retinitis Pigmentosa

Eye implants make vision-restoring progress

(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as ...

Jul 18, 2012
popularity 4.6 / 5 (10) | comments 4 | with audio podcast report

Inducing visual function

Scientists from the groups of Botond Roska and Witold Filipowicz at the Friedrich Miescher Institute for Biomedical Research have resolved the mechanism controlling the maintenance of the light sensitive ...

Jul 02, 2014
popularity 5 / 5 (3) | comments 0

Steve Wynn: University on path to blindness cure

Las Vegas casino tycoon Steve Wynn said Friday that he gave $25 million to support blindness research at the University of Iowa after becoming convinced that its scientists were leading the way in the search ...

Oct 19, 2013
popularity 4.8 / 5 (66) | comments 11

Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their 40s or 50s and retain some sight all their lives. Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case.

RP is a type of progressive retinal dystrophy, a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first experience defective dark adaptation or nyctalopia (night blindness), followed by reduction of the peripheral visual field (known as tunnel vision) and, sometimes, loss of central vision late in the course of the disease.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

One route to malaria drug resistance found

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious ...